Clinical trial Recruiting at 1 site Observational Ages 45 and up

Digital diagnosis and treatment system for sarcopenia

Official title: Establishment and Application of a Digital Diagnosis and Treatment System for Sarcopenia

Run by Peking Union Medical College Hospital · NCT06380777 · Data updated 2026-11-12

This study is testing a new digital system to help diagnose and treat sarcopenia in people aged 45 and older by providing early screening, medication, and rehabilitation programs tailored to their needs.

Quick facts

Study typeObservational
Ages45 Years and up
SexAll
Enrollment10000 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedSeptember 1, 2023
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedApril 24, 2024
Trial IDNCT06380777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 45 and older who meet the diagnostic criteria for sarcopenia.

Probably not a fit

Patients under 45 years old or those with acute chronic illnesses or cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a comprehensive digital system for diagnosing and treating sarcopenia. It integrates a digital vaccine for early screening, a digital drug for intervention, and a digital rehabilitation program for prevention. Participants aged 45 and older will be screened and monitored longitudinally, receiving tailored interventions based on their condition. The study seeks to create a visual tertiary prevention network to effectively manage sarcopenia.

Why it matters

Potential benefit: If successful, this approach could significantly improve early detection and management of sarcopenia, enhancing patient outcomes.

How similar studies have gone: While the integration of digital tools in managing sarcopenia is innovative, similar approaches in other conditions have shown promise, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥45 years;
* meeting sarcopenia diagnostic criteria;
* consent to participate in this study

Exclusion Criteria:

* Age \<45 years;
* patients in acute phase of chronic illness;
* infectious disease patients;
* people who lack of independent mobility;
* people who lack of communication or cognitive skills;
* people who refusal to participate in this study

Where it's running

  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.